| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Department of Obstetrics and
Gynecology and the Pacific Biomedical
Research Center, University of Hawaii
School of Medicine, Honolulu, Hawaii
The goal of this study was to investigate the relationship between cAMP and the fertilizing ability of
human spermatozoa. Levels of cAMP were measured in
human spermatozoa during 6-hour in vitro incubation
in capacitation medium, in both the presence and absence of phosphodiesterase (PDE) inhibitor. The fertilizing ability of the same samples was assayed with
zona-free hamster eggs. In the absence of PDE inhibitor, no relationship was apparent between mean cAMP
levels, which remained at 3-4 pmol cAMP/107 spermatozoa, and mean fertilizing ability, which increased
from 4% at the start of the incubation to 33% at 6 hours.
In the presence of PDE inhibitor (7 mM caffeine or 10
mM theophylline), cAMP concentrations increased
within minutes to 3-4 times control levels. Despite this
increase in cAMP, there was no immediate change in
fertilizing ability. This was true whether PDE inhibitor
was present from the start or added to control sperm
after 6 or 22 hours of incubation. However, once the
sperm were exposed to PDE inhibitor for 4-6 hours,
they fertilized a significantly greater proportion of eggs
than did control samples. These results suggest that
PDE inhibitors, or elevated cAMP levels, do not immediately induce the acrosome reaction, but rather appear
to reduce the amount of time required for capacitation
to occur in vitro.
Key words: capacitation of human spermatozoa, cAMP in human spermatozoa, fertilization of zona-free hamster eggs
Accepted on July 2, 1982
This article has been cited by other articles:
![]() |
P. Visconti, G. Moore, J. Bailey, P Leclerc, S. Connors, D Pan, P Olds-Clarke, and G. Kopf Capacitation of mouse spermatozoa. II. Protein tyrosine phosphorylation and capacitation are regulated by a cAMP-dependent pathway Development, January 4, 1995; 121(4): 1139 - 1150. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |